Nurocor, Inc Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Executives responsible for Clinical Operations are faced with ever increasing pressures to reduce costs and achieve quality by design, while meeting timelines and increasing productivity of Trial Execution Teams. Nurocor has developed an automation solution that saves $8,000,000 and 8 months for each Phase 3 trial. The Nurocor solution maximizes the value of existing system through built in connectivity enabling high value staff to focus on critical tasks not the mundane. Let Nurocor show you hoView more